Suprima lor throat tablets. Suprima - ENT - successful treatment of throat diseases

Tradename: SUPRIMA-ENT

INN: 2,4-dichlorobenzyl alcohol, amylmetacresol

Dosage form:

Lozenges with orange, lemon, honey and lemon, strawberry or eucalyptus aroma.

Compound:

Each tablet contains:
Active substances -
2,4-dichlorobenzyl alcohol………. 1.2 mg
amylmetacresol ………………………. 0.6 mg.
Excipients: sugar, liquid glucose, citric acid, menthol, dye, flavor.

Pharmacotherapeutic group:

antiseptic, antimicrobial combined agent.
ATC code: R02AA20

Pharmacological properties:

Combined antiseptic drug for topical use in the oral cavity and pharynx. It has an antimicrobial effect. Active against gram-positive and gram-negative microorganisms. Due to low systemic absorption, there are no data on the pharmacokinetics of SUPRIMA-LOR.

Indications for use:

It is used for the symptomatic treatment of infectious and inflammatory diseases of the oral cavity and pharynx. The effectiveness of the drug is due to the presence of two broad-spectrum antibacterial components.

Contraindications:

Hypersensitivity to the components of the drug.

Warnings:
Do not exceed the indicated dose.
When prescribing to patients with diabetes, it must be borne in mind that the tablets contain sugar.

Dosage and administration:
Recommended for adults and children over 6 years of age.
When the first symptoms of inflammation appear in the oral cavity and pharynx, it is recommended:
Adults - 1 tablet every 2 hours
The maximum daily dose is 8 tablets.
Children over 6 years old - 1 tablet every 4 hours.
The tablet should be sucked until completely dissolved.

Interaction with other medicinal substances:
No clinically significant interaction of SUPRIMA-LOR with drugs from other groups has been identified.

Side effects:
When used according to the indications in the recommended doses, no side effects of the drug were noted.

Release form:

lozenges with orange flavor, lemon flavor, honey and lemon flavor, strawberry flavor, eucalyptus flavor.

Storage conditions:

In a dry place, at a temperature not exceeding 25°C.
Keep out of reach of children.

Best before date:

3 years.
Do not use the drug after the expiry date which is stated on the package.

Manufacturer:

SHREYA LIFE SCIENCES Pvt. Ltd., India.

Released without a doctor's prescription.

Dichlorobenzyl alcohol, amylmetacresol, sucrose, citric acid, dextrose, various dyes (honey-lemon, orange, eucalyptus, lemon, strawberry, pineapple, menthol, raspberry).

Release form

Lozenges with orange flavor in a strip of 4 tablets in a carton No. 16.

pharmachologic effect

Antimicrobial, antiseptic, anti-inflammatory, analgesic.

Pharmacodynamics and pharmacokinetics

Pharmacodynamics

Suprima-ENT belongs to the group of oral antiseptic drugs widely used in the treatment of dental and otolaryngological infectious and inflammatory diseases. It contains two active components: 2,4-dichlorobenzyl alcohol - widely used as an antiseptic. The antiseptic effect is due to its ability to slow down the supply of pathogenic microflora cells with water, which slows down the process of their growth and reproduction and partial death.

Amylmetacresol - derivative, causes coagulation of the intracellular protein of microorganisms, which disrupts the process of its synthesis, and as a result, slows down the growth and reproduction of microorganisms. Amylmetacresol It also has a mild local anesthetic effect.

Various essential oils that are part of it and reduce the intensity of coughing, improve nasal breathing. Suprima-ENT exhibits a pronounced antiseptic effect against both gram-positive and gram-negative microflora, and also has a fungicidal effect on fungi of the genus Candida .

Due to this spectrum of pharmacological action, the drug can be used not only as a therapeutic agent for diseases of the pharynx and oral cavity of infectious origin, but also used for prophylactic purposes. The drug effectively reduces pain, nasal congestion, and irritation of the mucous membrane of the upper respiratory tract.

Pharmacokinetics

No data.

Indications for use

In the complex therapy of diseases of the pharynx and oral cavity of infectious and inflammatory genesis (,).

Contraindications

High sensitivity to the drug, age up to 6 years. The use of Suprim Lor during pregnancy is possible only according to indications under the supervision of a physician.

Side effects

Suprima-Lor, instructions for use (Method and dosage)

Suprima-Lor tablets must be sucked until it is completely dissolved. Take at the onset of early symptoms. Dosage - 1 tablet every 2 hours, for children after six years, the interval between doses increases to 4 hours. Do not exceed the maximum dosage - 8 tablets / day.

Overdose

Interaction

No clinically pronounced interaction of Suprima-ENT with other drugs has been identified.

Terms of sale

OTC sale.

Storage conditions

At a temperature of 10-25°C.

Best before date

Analogues

Coincidence in the ATX code of the 4th level:

Drugs with similar pharmacological action include: Astracept , Dinstril , Gorpils , Septoral , Lightel , Dinstril-Lemon Elfacept , Terasil and others.

Reviews about Suprima-Lor

Reviews about the drug among patients are good. Most of them note that the drug relieves inflammation in the throat and oral cavity well.

« ... With the onset of cold weather, colds begin in our family. Most often the throat suffers, the doctor advised Suprima-Lor. I bought it and don't regret it. Significantly relieves throat discomfort».

Some complain that they cannot find Suprima-Lor ointment. This is not surprising, since this drug is not available in such a dosage form. Many confuse this drug with ointment Suprima Plus produced by the same manufacturer. This ointment has other active ingredients and is applied externally.

Suprima-Lor price, where to buy

The price of Suprima-ENT tablets No. 16 varies between 85-103 rubles per pack. In the pharmacy chain of Moscow, you can buy without difficulty.

Internet pharmacies in Russia Russia

ZdravCity

Suprima-Lor tablets for rassas. strawberries 16 pcs. Shreya Life Sciences Pvt.Ltd

Suprima-Lor tablets for rassas. honey-lemon 16 pcs. Shreya Life Sciences Pvt.Ltd

Suprima-Lor tablets for rassas. orange 16 pcs. Shreya Life Sciences Pvt.Ltd

Suprima-LOR (Suprima-LOR)

Compound

1 lozenge of Suprima-ENT contains:

active ingredients:

2,4-dichlorobenzyl alcohol (Spiritus dichlorobenzylicus) - 1.2 mg,
amylmetacresol (Amylmetacresolum) - 0.6 mg;

Excipients: sugar, liquid glucose, citric acid, menthol. The coloring and flavoring content varies depending on the taste of the tablets.

pharmachologic effect

The drug Suprima-LOR is a prominent representative of oral antiseptics, which are used for infectious and inflammatory diseases in dentistry and otolaryngology.

One of the active components of the drug - 2,4-dichlorobenzyl alcohol (2,4-DHBS) - is very widely used in medicine as an antiseptic. The manifestation of the antiseptic effect occurs due to the ability to prevent the entry of water into the cells of microorganisms, resulting in a delay in growth and reproduction, as well as the death of microorganism cells (bactericidal and bacteriostatic pharmacological activity). There is also evidence of the ability of 2,4-DCBS to affect respiratory syncytial and coronaviruses, but it has no effect on rhinoviruses and adenoviruses.

Amylmetacresol is chemically a derivative of phenol. It contributes to the coagulation of the protein inside the cells of microorganisms, which causes the impossibility of its synthesis, as a result of which the growth and ability to reproduce microorganism cells slows down until they die. The above mechanism of action of the substance contributes to the manifestation of pronounced antimicrobial activity. Amylmetacresol also exhibits a local anesthetic therapeutic effect.

Due to the presence of essential oils, Suprima-LOR facilitates nasal breathing and reduces the intensity of coughing, providing a softening effect in areas of inflammation.

Due to the combination of two components in its composition, Suprima-LOR, which exhibit a pronounced antiseptic (antibacterial) effect, which, moreover, is enhanced by the presence of mutual synergistic properties of both components, exhibits pronounced activity against many gram-positive and gram-negative microorganisms (staphylococcus aureus, diplococcus, Klebsiella, Proteus and other aerobic and anaerobic pathogens). Suprima-ENT is also able to have a fungicidal effect on fungi of the genus Candida - this fact is another positive characteristic of the drug, since inflammation of the mucous membrane of the mouth and throat is very often accompanied by candidiasis.

Thus, the drug Suprima-ENT is a combination drug with a pronounced antiseptic, analgesic, local anesthetic and anti-inflammatory activity. Due to a wide range of pharmacological effects, Suprima-LOR is used both for preventive purposes and for the treatment of various infectious and inflammatory diseases in the oral cavity and pharynx, accompanied by pain and other symptoms that cause discomfort and significantly reduce the quality of life. The drug reduces pain and sore throat, nasal congestion, relieves irritation of the mucous surface of the upper respiratory tract.

Showing preventive properties, the drug Suprima-LOR prevents the fixation (localization) and reproduction of bacteria that have entered the body (mainly by airborne droplets) on the mucous membrane of the oral cavity and throat.

Also, Suprima-ENT is effective in case of inflammatory processes in dental practice (stomatitis, periodontal disease, pain as a result of various dental procedures).

The results of studies carried out during the development of the drug indicated the presence of an antiviral effect. Therefore, the use of Suprima-Lor is relevant not only in the case of inflammatory diseases of the oral cavity and throat of a bacterial or fungal nature, but also of a viral etiology.

The pharmacokinetics of the drug has not been studied, because the active components are practically not absorbed in the body and do not enter the systemic circulation and, therefore, do not have a negative effect, but have a therapeutic effect of local localization.

Indications for use

The drug Suprima-Lor is used for prophylactic and therapeutic purposes in relation to infectious and inflammatory diseases of the oral cavity and pharynx of a bacterial, fungal or viral nature (including in dental practice). It is prescribed to eliminate characteristic symptoms (pain and sore throat, cough, nasal congestion, dental pain, etc.). Suprima-ENT is indicated for the following diseases:

angina;
tonsillitis;
pharyngitis;
nasopharyngitis;
laryngitis (including professional, which occurs when the vocal cords are overstressed);
stomatitis;
gingivitis;
periodontal disease;
pain syndrome caused by various dental procedures.

Mode of application

Suprima-Lor is intended for patients aged 6 years and older. Take the drug orally. The tablet must be sucked in the mouth until completely dissolved.

After taking the drug, it is undesirable to drink and eat for at least 15-20 minutes, otherwise the therapeutic effect is significantly reduced, since the drug, which is localized and acts in the areas of inflammation on the oral mucosa, leaves the localization sites along with food and drinks.

If the doctor has not prescribed otherwise, then the drug is taken in accordance with the dosage regimen below:

adults and children over 12 years old: 1 tablet every 2 hours. The highest daily dose (VSD) of the drug is 8 tablets;
Children over 6 years: 1 tablet every 4 hours. VSD is 4 tablets.

Caution is required when used in patients with a history of diabetes mellitus, since Suprima-LOR contains sugar in its composition.

Suprima-ENT does not adversely affect the speed of psychomotor reactions and concentration.

Contraindications

Taking the drug Suprima-ENT is not allowed:

in the presence of sensitivity to the components of the drug;
children under 6 years old;
with a history of diabetes mellitus.

Pregnancy

There are no data from clinical studies in pregnant women due to the potential for harm to the newborn. Therefore, the use of Suprima-LOR is possible during pregnancy and lactation as prescribed by a doctor and only in agreement with a gynecologist.

drug interaction

Studies have confirmed the absence of a clinically significant interaction of Suprima-ENT with other drugs, but only if the recommended dosing regimen is observed. The absence of drug interactions is due to a very small percentage of drug absorption into the systemic circulation.

Overdose

In the presence of these symptoms, it is necessary to immediately stop taking the drug, seek medical help and continue the prescribed symptomatic treatment.

Release form

Suprima-Lor is available in the form of lozenges, which are presented in an assortment of different flavors:

orange;
lemon;
honey-lemon;
strawberry;
eucalyptus;
crimson;
pineapple;
menthol.

4 or 8 tablets. in a strip (aluminum) - 4 (2) in a cardboard box.

Depending on the taste, the tablets differ in color, however, all tablets are round in shape. When determining the physical properties of tablets, the manufacturer allows for color heterogeneity and roughness of the tablet surface, as well as the presence of small air bubbles in the caramel mass and a white coating on the surface of the tablet.

Storage conditions

Store in a dry place, out of the reach of children, at a temperature not exceeding 25°C. Shelf life - 3 years.

Synonyms

Strepsils, Ajisept, Astrasept, Gorpils, Dinstril, Lightel, Lorisils, RinzaLorsept, Terasil, Voka Sept.

Nosological classification (ICD-10)

Acute pharyngitis (J02)

Acute tonsillitis (J03)

Acute infection of the upper respiratory tract, multiple and unspecified (J06)

In this article, you can read the instructions for using the drug Suprima. Reviews of site visitors - consumers of this medicine, as well as opinions of doctors of specialists on the use of Suprima in their practice are presented. We kindly ask you to actively add your reviews about the drug: the medicine helped or did not help get rid of the disease, what complications and side effects were observed, perhaps not declared by the manufacturer in the annotation. Analogues of Suprima in the presence of existing structural analogues. Use for the treatment of bronchitis, laryngitis, pharyngitis and other inflammatory diseases of the mouth and throat in adults, children, as well as during pregnancy and lactation. The composition of the drug.

Suprima- a complex phytopreparation with bronchodilator, mucolytic, expectorant and anti-inflammatory action (Broncho).

Suprima KOF is a mucolytic agent. Stimulates prenatal development of the lungs (increases the synthesis, secretion of surfactant and blocks its decay). It has a secretomotor, secretolytic and expectorant effect; stimulates the serous cells of the glands of the bronchial mucosa, increases the content of the mucous secretion and the release of a surfactant (surfactant) in the alveoli and bronchi; normalizes the disturbed ratio of serous and mucous components of sputum.

By activating hydrolyzing enzymes and increasing the release of lysosomes from Clark cells, it reduces the viscosity of sputum.

Increases the motor activity of the ciliated epithelium, increases mucociliary transport. After ingestion, the action occurs within 30 minutes.

Suprima ENT is a combined antiseptic preparation for topical use in the oral cavity and pharynx. It has an antimicrobial effect. Active against gram-positive and gram-negative microorganisms.

The effectiveness of the drug is due to the presence of two broad-spectrum antibacterial components.

Pharmacokinetics

The effect of the drug Suprima-Broncho is the cumulative effect of its components, so pharmacokinetic studies are not possible.

Compound

Vasik adatoda extract + Licorice extract + Turmeric long extract + Sacred basil extract + Real ginger extract + Nightshade extract + Long pepper extract + Real cardamom extract + excipients (Suprima Broncho syrup).

Ambroxol hydrochloride + excipients (Suprim KOF tablets).

2,4-dichlorobenzyl alcohol + Amylmetacresol + excipients (Suprima ENT).

Camphor + Menthol + Eucalyptus oil + Thymol + Turpentine oil + excipients (Suprima Plus ointment).

Indications

Symptomatic therapy for inflammatory diseases of the respiratory tract, accompanied by cough:

SARS, influenza;
pharyngitis, laryngitis, tracheitis;
bronchitis, pneumonia;
the initial stages of whooping cough;
bronchial asthma with difficult sputum discharge;
bronchiectasis.

Chronic respiratory diseases:

smokers bronchitis;
lecturer's laryngitis.

Inflammatory diseases of the upper and lower respiratory tract, accompanied by cough, runny nose, nasal congestion (as part of complex therapy), as well as muscle pain.

Release form

Syrup Supreme Broncho.

Supreme KOF tablets.

Suprima ENT lozenges.

Ointment Suprima Plus.

Instructions for use and method of use

Syrup

Adults and children over 14 years old are prescribed 1-2 teaspoons (5-10 ml) 3 times a day.

Children from 6 to 14 years old - 1/2-1 teaspoon (2.5-5 ml) 3 times a day; from 3 years to 5 years - 1/2 teaspoon (2.5 ml) 3 times a day.

The course of treatment is 2-3 weeks.

KOF tablets

The drug is taken orally during a meal, with a small amount of liquid.

Adults and children over 12 years of age are prescribed 30 mg 3 times a day for the first 2-3 days, then 30 mg 2 times or 15 mg 3 times a day. In severe cases of the disease, the dose is not reduced during the entire course of treatment.

Children aged 5-12 years are prescribed 15 mg 2-3 times a day.

ENT lozenges

When the first symptoms of inflammation appear in the oral cavity and pharynx, it is recommended: for adults - 1 tablet every 2 hours. The maximum daily dose is 8 tablets. Children over 6 years old - 1 tablet every 4 hours.

The tablet should be sucked until completely dissolved.

Ointment Plus

For external use only!

To eliminate the symptoms of inflammatory diseases of the upper and lower respiratory tract, such as cough, runny nose, nasal congestion - rub into the skin of the chest and back 2-3 times a day.

For muscle pain, apply the ointment to the painful area. For best results, it is recommended to cover the painful area with a warm bandage.

Do not apply to damaged areas of the skin.

Side effect

weakness;
headache;
diarrhea;
dry mouth;
constipation;
nausea, vomiting;
skin rash;
hives;
bronchospasm (for ointment);
allergic reactions to the components of the drug.

Contraindications

tendency to bronchospasm (for ointment)
1st trimester of pregnancy (COF tablets);
children under 5 years of age (COF tablets);
hypersensitivity to the components of the drug.

Use during pregnancy and lactation

The use of the drug during pregnancy is possible only in cases where the intended benefit to the mother outweighs the potential risk to the fetus or child.

KOF tablets are forbidden to be taken in the 1st trimester of pregnancy.

Use in children

Suprima Broncho: Children from 6 to 14 years old - 1/2-1 teaspoon (2.5-5 ml) 3 times a day; from 3 years to 5 years - 1/2 teaspoon (2.5 ml) 3 times a day.

Suprima KOF: Children over 12 years of age are prescribed 30 mg 3 times a day for the first 2-3 days, then 30 mg 2 times or 15 mg 3 times a day. In severe cases of the disease, the dose is not reduced during the entire course of treatment. Children aged 5-12 years are prescribed 15 mg 2-3 times a day.

special instructions

At the same time, according to indications, the use of antimicrobial agents is possible.

When prescribing the drug to patients with diabetes, it should be borne in mind that Suprim Broncho in 5 ml of syrup (1 teaspoon) contains 1.5 g of sugar.

drug interaction

The combined use of Suprim KOF with antitussive drugs (for example, those containing codeine) leads to difficulty in sputum discharge against the background of a decrease in cough.

Clinically significant interaction of the drug Suprim Broncho with other drugs has not been described.

Analogues of the drug Suprima

Suprima has no structural analogues for the active substance.

Analogues for the pharmacological group (secretolitics):

Ambrobene;
Ambroxol;
Ambrosan;
Ambrosol;
Amtersol;
Ascoril;
Acetylcysteine;
ACC Long;
Bromhexine;
Bronchicum;
Bronchicum cough syrup;
Bronchipret;
Bronchostop;
Bronchothil;
Gedelix;
GeloMyrtol;
Herbion;
Breast collection;
Breast elixir;
Deflegmin;
Joset;
Dr. MOM;
Dr. Theiss;
Zedex;
Insty;
Carbocysteine;
Codelac Broncho;
Coldrex broncho;
Lazolvan;
Libeksin Muko;
Linkas Balm;
Mukaltin;
Mukobene;
Mukosol;
expectorant collection;
Pectusin;
Pertussin;
Prospan;
Rinicold Broncho;
Sinupret;
Licorice root;
Solutan;
Stoptussin;
Suprima COF;
Cough tablets;
Terpinhydrate;
Travisil;
Tussamag;
Tussin;
Tussin plus;
Fervex for cough;
Flavamed;
Fluimucil;
Fluifort;
Halixol;
Erdomed.

In the absence of analogues of the drug for the active substance, you can follow the links below to the diseases that the corresponding drug helps with and see the available analogues for the therapeutic effect.

Many colds are accompanied by a sore throat. It gets worse when a bacterial infection joins. If the body can cope with viral pathologies on its own, then antibiotics and antiseptics will be needed to eliminate harmful microorganisms. Often doctors prescribe complex treatment. Doctors prescribe general medicines (for oral or injection use) and topical remedies (for treating the throat). In today's article, your attention will be presented with instructions for the use of Suprima-ENT. You can learn a lot of useful things about this drug.

Description: types of the drug "Suprima"

The medicine "Suprima-ENT" is produced by the manufacturer in several forms. The general line is called "Suprima". It includes syrup, ointment and lozenges. Each drug has a separate purpose and method of use. All medicines are sold without a prescription and have an affordable price. In the pharmacy you can buy the following products:

"Suprima-ENT" - ointment. Instructions for use advises using this remedy for coughs, nasal congestion and muscle pain. Its trade name is Suprima Plus.
"Suprema Broncho". This medicine comes in the form of a syrup. The remedy is used for coughs of various origins: pneumonia, bronchitis, laryngitis, tracheitis, and so on.
"Suprima-ENT". Tablets instructions for use recommends prescribing for diseases of the mouth and pharynx.

The composition of the drug "Suprima-ENT" and its cost

In addition to the described variations of the line, they have a separate division of the Suprima-ENT tablet. The medicine has different flavoring additives. But this does not change the principle of the drug. The active ingredient in lozenges is amylmetacresol. Also, for the preparation of the drug, the manufacturer uses dextrose, sucrose, citric acid, levomenthol, dyes and appropriate flavors.

In the pharmacy, you can buy medicine with the following flavors: menthol, orange, lemon, eucalyptus, pineapple, raspberry, honey and strawberry. All funds cost about the same. 16 lozenges will cost you no more than 150 rubles. Please note that the drug refers to antibiotics.

Indications for use

You already know that Suprima preparations are prescribed for infectious diseases. "Suprima-ENT" (syrup) instructions for use recommend using for the treatment of cough. The ointment is used for nasal congestion and as a warming agent. Pastilles are able to eliminate infectious manifestations in the throat and oral cavity. Together, this line of products accelerates recovery from viral and bacterial pathologies.

Instructions for use "Suprima-ENT" (tablets) recommends the use of the remedy for the following diseases:

stomatitis;
gingivitis;
tonsillitis in acute and chronic form;
glossitis and pharyngitis;
tracheitis and laryngitis.

A medication is prescribed to prevent the development of infection after various manipulations, for example, tooth extraction.

In what situations is treatment contraindicated?

Any medicine of the Suprima line is not used in case of sensitivity to its components. Otherwise, each drug has its own limitations. Instructions for use "Suprima-ENT" does not advise the use of tablets for children under the age of 6 years. What other useful information can be found? What does the instructions for use say about Suprima-ENT? During pregnancy, the use of the drug is permissible only after prior consultation with the doctor. With his permission and after receiving individual recommendations, the expectant mother can take the medicine. The use of the drug during lactation has not been studied. There is no guarantee that the active ingredients will not pass to the baby through breast milk.

The instructions for use do not indicate that the medication should not be taken with diabetes. But doctors give such information. The composition of the drug includes sugar. Its impact can adversely affect the course of the disease. That is why it is so important not to self-medicate, but to contact a specialist with existing complaints.

Instructions for use: Suprima-ENT lozenges

The annotation states that each tablet should remain in the mouth until completely dissolved. It is unacceptable to pre-grind the lozenge or gnaw it. When treating children, detailed explanations should be given in this regard.

For children, the medication is prescribed one lollipop every 4 hours. It is allowed to take no more than 6 lozenges per day. Adult patients can use the medication every 2 hours, but not more than 8 tablets per day. Treatment should be started as early as possible, at the first symptoms of the disease. In this case, the maximum effect will be achieved. You need to use the medicine for the period that the doctor sets. Usually, doctors prescribe medication for 5-7 days. In some situations, one-day use is recommended (for example, after surgery).

Other forms of the drug "Suprima": instructions

How is the ointment and syrup of this line used? Instructions for use recommends applying the balm to the back, chest and neck. It is advisable to carry out the manipulation before going to bed. It is permissible to rub the feet for a warming effect. It is important that the patient does not have a temperature. "Suprima-plus" is used in children only after two years.

"Suprima-broncho" is prescribed at a dose of 2.5-10 milliliters three times a day. The dose of the drug depends on the age of the patient. In children, the medicine is used only after three years.

How the medicine works in tablets

Instructions for use "Suprima-ENT" says that its active ingredients are antibacterial components. They have an antiseptic and antimicrobial effect. The components are effective against gram-positive and gram-negative bacteria. The components have a wide spectrum of action. The manufacturer says that there is no data on the pharmacokinetics of the drug. This is due to the fact that only small doses of active substances can be absorbed into the bloodstream.

The medicine during resorption affects the microorganisms located in the oral cavity and on the pharynx. Lozenges increase salivation, which, in turn, helps to cleanse the mucous membranes.

Side effects

About the drug "Suprima-ENT" instructions for use, reviews of consumers and doctors report the following: the medication is well tolerated by patients. Only in some cases there are adverse reactions to its use. They are allergic. If you experience reddening of the skin, itching or swelling, then the treatment should be stopped. Contact your doctor for further advice. Please note that the allergen may not be an active antibiotic, but an additional component or dye.

The use of the drug in large doses contributes to the appearance of nausea, vomiting or the development of diarrhea. These unpleasant consequences disappear on their own after the drug is discontinued. Only in special cases, doctors can prescribe sorbents.